ARTICLES BY ERIC LANGER
-
![iStock-517894805]( "Cell And Gene Therapy Bioprocessing: Hiring And Capacity Crunch On The Horizon")
Cell And Gene Therapy Bioprocessing: Hiring And Capacity Crunch On The Horizon5/21/2020With a very healthy R&D pipeline of cell and gene therapies, we can expect multiple blockbuster products and various “orphan” niche products to be launched annually in coming years. As a result, the industry is heading for a capacity crunch.
Eric Langer
Eric S. Langer is president and managing partner at BioPlan Associates, Inc., a biotechnology and life sciences marketing research and publishing firm established in Rockville, MD, in 1989. He is editor of numerous studies, including Biopharmaceutical Technology in China, Advances in Large-scale Biopharmaceutical Manufacturing, and many other industry reports. You can reach him at elanger@bioplanassociates.com or 301-921-5979.
This website uses cookies to ensure you get the best experience on our website. Learn more